insideedgeconsulting.blogspot.com
The INSIDE EDGE: Events & Meetings
http://insideedgeconsulting.blogspot.com/p/events.html
Uncover, Connect, and Execute Your Opportunity. Back to IE Website. Click on the following links to see meetings and conventions. American College of Cardiology. American Health Insurance Plans. American Society of Health-System Pharmacists. Academy of Managed Care Pharmacy. American Society of Hypertension. Nternational Society on Hypertension in Blacks. Subscribe to: Posts (Atom). Three Ways to Put Innovation Back into Medical Edu. 4 Causes for Optimism in Healthcare. Doing Big Data In Healthcare.
carolrupemd.com
Carol Rupe MD - Clinical Office Closure & Medical Records Information
https://www.carolrupemd.com/index.php/clinical-office-closing-information
Great Family Medicine with Hometown Warmth and Understanding. Roanoke Clinic Office Phone: 252.537.9176. Hours of Operation: M - F 7am - 5pm. Monday, 18 May 2015 11:48. Clinical Office Closing Information. Dr Rupe’s Office officially closed, effective Thursday, May 14. Thank you for your friendship all these years and the best of health in the years to come. All unclaimed records have now been transferred to Mountain View Medical Services:. Mountain View Medical Services. 7804 Fairview Road PMB # 221.
insideedgeconsulting.blogspot.com
The INSIDE EDGE: March 2015
http://insideedgeconsulting.blogspot.com/2015_03_01_archive.html
Uncover, Connect, and Execute Your Opportunity. Back to IE Website. The American College of Cardiology (ACC) Scientific Sessions were held last week, at which there were many exciting. Were updates on Phase 3 studies for alirocumab and evolocumab. Phase 2 data was presented on. Just following ACC, Phase 2. Data was presented on ETC-1002. This category of cholesterol management is definitely heating up. Those in the industry feel that. The first products will be launched in. A key target for these agents.
insideedgeconsulting.blogspot.com
The INSIDE EDGE: February 2015
http://insideedgeconsulting.blogspot.com/2015_02_01_archive.html
Uncover, Connect, and Execute Your Opportunity. Back to IE Website. The process of developing drugs is long and expensive; the process of prescribing and ensuring patient compliance with the drug regimen is also complex. Once a medication is prescribed, there is no clear way to assess if it is being taken and how it is being taken by the patient. At the end of the day, there is no impact either for the company or the patients. ISHIB has executed two community programs to date. Participating patients rece...
insideedgeconsulting.blogspot.com
The INSIDE EDGE: Trends in Managed Care
http://insideedgeconsulting.blogspot.com/2015/04/trends-in-managed-care.html
Uncover, Connect, and Execute Your Opportunity. Back to IE Website. Trends in Managed Care. Earlier this month the Academy of Managed Care Pharmacists (AMCP) met in San Diego which. Afforded them the opportunity discuss and share information on the top trends in managed care. For those that follow managed care pharmacy, none of these will come as a surprise, but the following were the group’s main concerns:. Spending in specialty care and the future growth of this market. What to do about PCSK9s. This is...
insideedgeconsulting.blogspot.com
The INSIDE EDGE: May 2015
http://insideedgeconsulting.blogspot.com/2015_05_01_archive.html
Uncover, Connect, and Execute Your Opportunity. Back to IE Website. Pharmacy benefit vs. medical benefit. Specialty pharmacy has become a bigger concern for managed care, particularly plans and employers. With this in mind, it is probably important to take a step back to understand the differences between pharmacy benefits vs. medical benefits. A simple definition is:. Health plans and employers are most interested in understanding how a shift could assist them in reducing costs, and there are many facto...
insideedgeconsulting.blogspot.com
The INSIDE EDGE: Biosimilars in Europe
http://insideedgeconsulting.blogspot.com/2015/04/biosimilars-in-europe.html
Uncover, Connect, and Execute Your Opportunity. Back to IE Website. Biosimilar approvals may be new to the FDA, but EMA has been approving biosimilars since 2006. The first biosimilar approved by the EMA was Genotropin (somatropin) a human growth hormone manufactured by Pfizer. Since then, the adoption of biosimilars in Europe has been strong, although it does differ by drug and drug classes with no specific pattern evident. In 2005, the EMA provided its Guideline on Similar Biological Medicinal Products.
insideedgeconsulting.blogspot.com
The INSIDE EDGE: December 2014
http://insideedgeconsulting.blogspot.com/2014_12_01_archive.html
Uncover, Connect, and Execute Your Opportunity. Back to IE Website. Happy holidays from all of us at IE. At the end of each year, the IE team likes to take a few minutes to reflect and thank our partners and clients across many different sectors and focus areas for the opportunities to support the work they do in healthcare. We are blessed to be able to contribute in a small way to the shared ultimate goal of making people across the world healthier. Inside Edge Consulting, Princeton. Follow Us on Twitter.
insideedgeconsulting.blogspot.com
The INSIDE EDGE: January 2015
http://insideedgeconsulting.blogspot.com/2015_01_01_archive.html
Uncover, Connect, and Execute Your Opportunity. Back to IE Website. Having focused on managed care organizations for the last four years and the insights provided by their decision makers, I have been struck by the overwhelming skepticism which surrounds the data and information that pharmaceutical manufacturers provide to managed care organizations. Pharmaceutical manufacturers are interested in drug revenues across the whole population and their slice of the market share pie. The feeling overall is tha...
SOCIAL ENGAGEMENT